Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Sunshine Biopharma Inc.

    NASDAQ: SBFM · Real-Time Price · USD
    1.60
    0.05 (3.23%)
    At close: Jun 16, 2025, 3:59 PM
    1.61
    0.31%
    Pre-market: Jun 17, 2025, 08:55 AM EDT

    Sunshine Biopharma Statistics

    Share Statistics

    Sunshine Biopharma has 4.56M shares outstanding. The number of shares has increased by -85.7% in one year.

    Shares Outstanding

    n/a
    		 4.56M

    Shares Change (YoY)

    n/a
    		 -85.7%

    Shares Change (QoQ)

    n/a
    		 35.44%

    Owned by Institutions (%)

    n/a
    		 0%

    Shares Floating

    n/a
    		 4.55M

    Failed to Deliver (FTD) Shares

    n/a
    		 10,988

    FTD / Avg. Volume

    n/a
    		 0.76%

    Short Selling Information

    The latest short interest is 153.86K, so 3.38% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 153.86K

    Short % of Shares Out

    n/a
    		 3.38%

    Short % of Float

    n/a
    		 3.38%

    Short Ratio (days to cover)

    n/a
    		 1.55

    Valuation Ratios

    The PE ratio is -0.41 and the forward PE ratio is null. Sunshine Biopharma's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.41

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0.06

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 0.09

    P/FCF Ratio

    n/a
    		 -0.14

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Sunshine Biopharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.11, with a Debt / Equity ratio of 0.04.

    Current Ratio

    n/a
    		 4.11

    Quick Ratio

    n/a
    		 2.33

    Debt / Equity

    n/a
    		 0.04

    Debt / EBITDA

    n/a
    		 -0.18

    Debt / FCF

    n/a
    		 -0.06

    Interest Coverage

    n/a
    		 -662.43

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $670,653.85

    Profits Per Employee

    n/a
    		 $-98,730.77

    Employee Count

    n/a
    		 52

    Asset Turnover

    n/a
    		 1.14

    Inventory Turnover

    n/a
    		 2.15

    Taxes

    Income Tax

    n/a
    		 -235K

    Effective Tax Rate

    n/a
    		 4.37%

    Stock Price Statistics

    The stock price has increased by -73.6% in the last 52 weeks. The beta is 0.96, so Sunshine Biopharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.96

    52-Week Price Change

    n/a
    		 -73.6%

    50-Day Moving Average

    n/a
    		 1.43

    200-Day Moving Average

    n/a
    		 2.39

    Relative Strength Index (RSI)

    n/a
    		 56.81

    Average Volume (20 Days)

    n/a
    		 1,444,520

    Income Statement

    In the last 12 months, Sunshine Biopharma had revenue of 34.87M and earned -5.13M in profits. Earnings per share was -7.32.

    Revenue

    n/a
    		 34.87M

    Gross Profit

    n/a
    		 10.67M

    Operating Income

    n/a
    		 -5.81M

    Net Income

    n/a
    		 -5.13M

    EBITDA

    n/a
    		 -5.15M

    EBIT

    n/a
    		 -5.36M

    Earnings Per Share (EPS)

    n/a
    		 -7.32
    Full Income Statement

    Balance Sheet

    The company has 9.69M in cash and 952.48K in debt, giving a net cash position of 8.73M.

    Cash & Cash Equivalents

    n/a
    		 9.69M

    Total Debt

    n/a
    		 952.48K

    Net Cash

    n/a
    		 8.73M

    Retained Earnings

    n/a
    		 -69.04M

    Total Assets

    n/a
    		 30.56M

    Working Capital

    n/a
    		 19.65M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -12.53M and capital expenditures -2.32M, giving a free cash flow of -14.85M.

    Operating Cash Flow

    n/a
    		 -12.53M

    Capital Expenditures

    n/a
    		 -2.32M

    Free Cash Flow

    n/a
    		 -14.85M

    FCF Per Share

    n/a
    		 -21.16
    Full Cash Flow Statement

    Margins

    Gross margin is 30.6%, with operating and profit margins of -16.67% and -14.72%.

    Gross Margin

    n/a
    		 30.6%

    Operating Margin

    n/a
    		 -16.67%

    Pretax Margin

    n/a
    		 -15.4%

    Profit Margin

    n/a
    		 -14.72%

    EBITDA Margin

    n/a
    		 -14.78%

    EBIT Margin

    n/a
    		 -16.67%

    FCF Margin

    n/a
    		 -42.59%

    Dividends & Yields

    SBFM does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for SBFM is $15, which is 837.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $15

    Price Target Difference

    n/a
    		 837.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Aug 8, 2024. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Aug 8, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -1.27

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist